Immunogenicity and safety of a tetravalent measles-mumps-rubella-varicella vaccine co-administered with a booster dose of a combined diphtheria-tetanus-acellular pertussis-hepatitis B-inactivated poliovirus-Haemophilus influenzae type b conjugate vaccine in healthy children aged 12-23 months. [electronic resource]
Producer: 20080124Description: 857-64 p. digitalISSN:- 0340-6199
- Analysis of Variance
- Antibodies, Bacterial -- blood
- Antibodies, Viral -- blood
- Chickenpox Vaccine -- administration & dosage
- Diphtheria-Tetanus-Pertussis Vaccine
- Enzyme-Linked Immunosorbent Assay
- Female
- Fever -- chemically induced
- Haemophilus Vaccines
- Hepatitis B Vaccines
- Humans
- Immunization Schedule
- Immunization, Secondary -- adverse effects
- Infant
- Male
- Measles-Mumps-Rubella Vaccine -- administration & dosage
- Pain -- chemically induced
- Poliovirus Vaccine, Inactivated
- Skin Diseases -- chemically induced
- Vaccines, Combined -- administration & dosage
No physical items for this record
Publication Type: Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.